Document Detail


Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus.
MedLine Citation:
PMID:  3355277     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In an attempt to improve on the long-term survival rate of patients with esophageal squamous cell carcinoma, we designed a study in which treatment included preoperative chemotherapy with fluorouracil and cisplatin, surgical resection, and selective postoperative chemotherapy or radiation therapy. Between 1981 and 1986, 35 patients with potentially resectable lesions were entered into the study. After chemotherapy, 13 of 35 patients (37%) had a complete clinical response, 7 (20%) had a partial response, and 15 (43%) had no response. One patient sustained a serious toxic reaction (renal failure). Twenty-seven patients underwent surgical resection, with 1 hospital death (3.7%). Selective postoperative radiotherapy or chemotherapy was administered to 69%. The actuarial survival of all resected patients at 42 months was 54% (standard error, 10%). Multivariate analysis showed significant factors associated with 3-year survival were: (1) complete clinical response to chemotherapy; (2) absence of wall penetration in the specimen; and (3) microscopic or no disease in the specimen. We conclude that this multimodality treatment method improves the intermediate-term survival of patients with squamous cell carcinoma of the esophagus.
Authors:
A D Hilgenberg; R W Carey; E W Wilkins; N C Choi; D J Mathisen; H C Grillo
Related Documents :
18640307 - Lymph node analysis in esophageal resection: american college of surgeons oncology grou...
7531797 - Primary small-cell cancer of the esophagus.
24623597 - Treatment outcomes of post-radiation second head and neck malignancies (prt-shnm) manag...
9537207 - Closure of tracheoesophageal fistulas with chemotherapy and radiotherapy.
22085617 - Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma o...
10551557 - Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  45     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1988 Apr 
Date Detail:
Created Date:  1988-05-05     Completed Date:  1988-05-05     Revised Date:  2006-04-24    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  357-63     Citation Subset:  AIM; IM    
Affiliation:
Surgical Services, Massachusetts General Hospital, Boston 02114.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma, Squamous Cell / drug therapy,  mortality,  surgery,  therapy*
Cisplatin / administration & dosage
Combined Modality Therapy
Esophageal Neoplasms / drug therapy,  mortality,  surgery,  therapy*
Fluorouracil / administration & dosage
Humans
Chemical
Reg. No./Substance:
15663-27-1/Cisplatin; 51-21-8/Fluorouracil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of moderate hypothermia in the treatment of canine hemorrhagic shock.
Next Document:  Actuarial analysis of late results after closed mitral valvotomy.